Actively Recruiting
Study of Autoimmune Interstitial Lung Disease in Adults from Argentina Tracking Patient Characteristics, Treatments, and Outcomes Over 5 Years
Led by EPIMAR registry · Updated on 2022-05-06
1000
Participants Needed
1
Research Sites
234 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying autoimmune interstitial lung diseases Ai-ILD, a group of conditions that cause inflammation and scarring in the lungs. This study focuses on patients with Ai-ILD, including those with connective tissue disease-associated ILD, ANCA-associated ILD, and interstitial pneumonia with autoimmune features. The goal is to better understand the characteristics, progression, treatment patterns, and long-term outcomes over a five-year period. The study involves a prospective, observational registry called EPIMAR II, enrolling patients diagnosed with Ai-ILD within the last five years. Participants will have undergone evaluation by a multidisciplinary team including pulmonologists and rheumatologists. Patients will be followed annually for five years, with data collected on lung function, imaging results from high-resolution CT scans, treatments used, and adverse drug events. Patients may include those with or without respiratory symptoms, and the study will track disease progression and survival. Participants will have a baseline visit with a detailed medical history and review of recent lung imaging and lung function tests. Annual follow-up visits will assess lung function and imaging changes, treatment safety, and overall survival. The study will collect information on quality of life and healthcare resource use. The total participation duration is five years, with ongoing monitoring of disease status, treatment effects, and mortality outcomes.
CONDITIONS
Brief Title
Registry of Autoimmune Interstitial Lung Disease
Research Team
F
Florencia Vivero, MD
J
Juan Enghelmayer, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here